CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-22 | Anson Funds Management LP 10% owner | Purchase | +48,060 | $6.85 | $329K | 864,188 |
| 2023-09-22 | Anson Funds Management LP 10% owner | Sale · Put Option (obligation to buy) | −9,000 | $0.15 | $1K | 9,000 |
| 2023-09-22 | Funicular Funds, LP 10% owner | Purchase | +32,040 | $6.85 | $220K | 460,840 |
| 2023-09-22 | Funicular Funds, LP 10% owner | Sale · Put Option (obligation to buy) | −6,000 | $0.14 | $869 | 6,000 |
| 2023-09-21 | Anson Funds Management LP 10% owner | Purchase | +33,600 | $6.46 | $217K | 816,128 |
| 2023-09-21 | Funicular Funds, LP 10% owner | Purchase | +22,400 | $6.46 | $145K | 428,800 |
| 2023-09-20 | Anson Funds Management LP 10% owner | Purchase | +120,000 | $6.01 | $721K | 782,528 |
| 2023-09-20 | Funicular Funds, LP 10% owner | Purchase | +80,000 | $6.01 | $481K | 406,400 |
| 2023-06-02 | Urso David M President and CEO | Grant or award · Stock Option (Right to Buy) | +166,571 | 166,571 | ||
| 2023-02-28 | Baltic Charles V. III Director | Purchase | +81,500 | $0.23 | $18K | 105,750 |
| 2022-07-05 | KANGO SUJAY Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | GHALIE RICHARD G Chief Medical Officer | Shares withheld for taxes | −8,196 | $0.54 | $4K | 28,927 |
| 2022-07-05 | GHALIE RICHARD G Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +560,000 | 560,000 | ||
| 2022-07-05 | Baltic Charles V. III Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +87.5 | 87,500 | ||
| 2022-07-05 | Glover Nicholas Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | Cohen Cheryl Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2022-07-05 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,496,000 | 1,496,000 | ||
| 2022-07-05 | Drazba Brian G. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 |
Page 4 of 13 · 252 trades